Abstract
Objectives
To evaluate response, time to progression and survival of patients with limited disease (LD) small cell carcinoma of the bladder (SCCB) treated with sequential chemoradiation in analogy to LD small cell lung cancer (SCLC).
Methods
Of 42 patients with SCCB treated at our institution between 1993 and 2007, 17 with LD SCCB treated with chemoradiation were identified and retrospectively analysed. LD was defined as any pT, cN0-1, cM0. SCCB was defined according to WHO criteria. All patients had platinum-based chemotherapy after transurethral resection (TUR) prior to local radiotherapy with 56–70 Gy.
Results
Sixteen patients were male, 1 female. Median age was 62 years. Median overall survival is 32.5 months. All had a clinical local response (15 CR, 2 PR). Systemic progression occurred in 8 (47%) with a median time to progression of 6 months (range 1–16 months), 8 died with a median survival of 17.5 months. Currently, 7 are free of disease (FOD) including 2 at 80 and 87 months. Four (23.5%) had a local recurrence as late as 43 and 50 months; 3 required a salvage cystectomy.
Conclusions
Clinical results of sequential chemoradiation for LD SCCB are comparable to contemporary series of LD SCCB treated with cystectomy and upfront or adjuvant chemotherapy. Long-term survival of more than 5 years after chemoradiation can be achieved. The risk of local recurrence is lower than reported, but late recurrences occur. These data suggest that bladder sparing with systemic chemotherapy and local control by radiotherapy should be further investigated in this aggressive disease.
Similar content being viewed by others
References
Ibrahim NB, Briggs JC, Corbishley CM (1984) Extrapulmonary oat cell carcinoma. Cancer 54:1645–1661. doi:10.1002/1097-0142(19841015)54:8<1645::AID-CNCR2820540828>3.0.CO;2-Q
Cramer SF, Aikawa M, Cebelin M (1981) Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 47:724–730. doi:10.1002/1097-0142(19810215)47:4<724::AID-CNCR2820470417>3.0.CO;2-2
Hirsch FR, Matthews MJ, Aisner S, Campobasso O, Elema JD, Gazdar AF et al (1988) Histopathologic classification of small cell lung cancer. Changing concepts and terminology. Cancer 62:973–977. doi:10.1002/1097-0142(19880901)62:5<973::AID-CNCR2820620521>3.0.CO;2-O
Nabi G, Singh I, Ansari MS, Sharma MC, Dogra PN (2001) Primary small cell neuroendocrine carcinoma of urinary bladder: an uncommon entity to be recognized. Int Urol Nephrol 33:637–640. doi:10.1023/A:1020510130301
Yu DS, Chang SY, Wang J, Yang TH, Cheng CL, Lee SS et al (1990) Small cell carcinoma of the urinary tract. Br J Urol 66:590–595
Trias I, Algaba F, Condom E, Espanol I, Segui J, Orsola I et al (2001) Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol 39:85–90. doi:10.1159/000052417
Mills SE, Wolfe JT III, Weiss MA, Swanson PE, Wick MR, Fowler JE Jr et al (1987) Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 11:606–617. doi:10.1097/00000478-198708000-00004
Mackey JR, Au HJ, Hugh J, Venner P (1998) Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 159:1624–1629. doi:10.1097/00005392-199805000-00058
Holmang S, Borghede G, Johansson SL (1995) Primary small cell carcinoma of the bladder: a report of 25 cases. J Urol 153:1820–1822. doi:10.1016/S0022-5347(01)67320-8
Grignon DJ, Ro JY, Ayala AG, Shum DT, Ordonez NG, Logothetis CJ et al (1992) Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 69:527–536. doi:10.1002/1097-0142(19920115)69:2<527::AID-CNCR2820690241>3.0.CO;2-7
Christopher ME, Seftel AD, Sorenson K, Resnick MI (1991) Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. J Urol 146:382–388
Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ (1989) Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64:1347–1357. doi: 10.1002/1097-0142(19890915)64:6<1347::AID-CNCR2820640629>3.0.CO;2-Q
Lopez JI, Angulo JC, Flores N, Toledo JD (1994) Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases. Br J Urol 73:43–49
Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J et al (2005) Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. J Urol 174:93–96. doi:10.1097/01.ju.0000162085.20043.1f
Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL et al (2004) Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol 172:481–484. doi:10.1097/01.ju.0000132413.85866.fc
Comis RL, Friedland DM, Good BC (1998) Small-cell lung cancer: a perspective on the past and a preview of the future. Oncology 12:44–50 Williston Park
Simon GR, Wagner H (2003) Small cell lung cancer. Chest 123:259S–271S. doi:10.1378/chest.123.1_suppl.259S
Turrisi AT III (2003) Limited stage small cell lung cancer: treatment and therapy. Curr Treat Options Oncol 4:61–64. doi:10.1007/s11864-003-0032-9
Hirsch FR, Matthews MJ, Yesner R (1982) Histopathologic classification of small cell carcinoma of the lung: comments based on an interobserver examination. Cancer 50:1360–1366. doi:10.1002/1097-0142(19821001)50:7<1360::AID-CNCR2820500723>3.0.CO;2-S
Ueda H, Kuwahara M, Sakada T, Motohiro A (2002) Chemotherapy for small cell lung cancer in patients over 80 years old. Anticancer Res 22:3629–3631
Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF et al (1996) Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 14:806–813
Hand S, Baker J, Smith AP, Macbeth FR (2002) Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified ‘ICE’ ifosfamide carboplatin and etoposide. Clin Oncol (R Coll Radiol) 14:367–371. doi:10.1053/clon.2002.0097
Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S et al (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054–3060. doi:10.1200/JCO.2002.12.071
Johnson BE, Grayson J, Makuch RW, Linnoila RI, Anderson MJ, Cohen MH et al (1990) Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol 8:396–401
Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van BH, Meinhardt W, Horenblas S (2005) Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 65:295–299. doi:10.1016/j.urology.2004.09.049
Lester JF, Hudson E, Barber JB (2006) Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature. Clin Oncol (R Coll Radiol) 18:608–611. doi:10.1016/j.clon.2006.06.009
Choong NW, Quevedo JF, Kaur JS (2005) Small cell carcinoma of the urinary bladder. The mayo clinic experience. Cancer 103:1172–1178. doi:10.1002/cncr.20903
Lohrisch C, Murray N, Pickles T, Sullivan L (1999) Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer 86:2346–2352. doi:10.1002/(SICI)1097-0142(19991201)86:11<2346::AID-CNCR24>3.0.CO;2-5
Oblon DJ, Parsons JT, Zander DS, Wajsman Z (1993) Bladder preservation and durable complete remission of small cell carcinoma of the bladder with systemic chemotherapy and adjuvant radiation therapy. Cancer 71:2581–2584. doi:10.1002/1097-0142(19930415)71:8<2581::AID-CNCR2820710824>3.0.CO;2-6
Bastus R, Caballero JM, Gonzalez G, Borrat P, Casalots J, Gomez de Segura G et al (1999) Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: results in five cases. Eur Urol 35:323–326. doi:10.1159/000019870
Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H et al (2004) Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–962. doi:10.1002/cncr.20456
Chen WC, Liaw CC, Chuang CK, Chen MF, Chen CS, Lin PY et al (2003) Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 56:726–733. doi:10.1016/S0360-3016(03)00124-X
Hagan MP, Winter KA, Kaufman DS, Wajsman Z, Zietman A, Heney NM et al (2003) RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57:665–672. doi:10.1016/S0360-3016(03)00718-1
Kaufman DS, Winter KA, Shipley WU, Heney NM, Chetner MP, Souhami L et al (2000) The initial results in muscle-invading bladder cancer of RTOG 95–06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5:471–476. doi:10.1634/theoncologist.5-6-471
Author information
Authors and Affiliations
Corresponding author
Additional information
A. Bex and R. de Vries contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Bex, A., de Vries, R., Pos, F. et al. Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. World J Urol 27, 101–106 (2009). https://doi.org/10.1007/s00345-008-0304-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-008-0304-x